Literature DB >> 16025417

Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing.

J Gallinat1, D Kunz, U E Lang, P Kalus, G Juckel, J Eggers, R Mahlberg, M Staedtgen, C Wernicke, H Rommelspacher, M N Smolka.   

Abstract

BACKGROUND: Cigarette smoking has been associated with mood enhancing properties and modulating effects on serotonin activity. The loudness dependence (LD) of the auditory-evoked N1/P2-component has been related to serotonergic neurotransmission, i. e. the allelic variants in the promoter of the 5-hydroxytryptamine-transporter (5-HTT) gene (SCL6A4). Moreover, smoking behavior has been associated to the 5-HTT-genotype. It was hypothesized that cigarette smoking modulates the LD and this effect was expected to interact with the 5-HTT-genotype.
METHODS: 5-HTT-genotype and LD were determined in 63 healthy smokers and 114 nonsmokers.
RESULTS: LD was significantly affected by smoking status (p = 0.008) and 5-HTT-genotype (p = 0.045) but not by smoking*genotype-interaction or daily cigarette consumption. Current smokers exhibited a significantly weaker LD compared to nonsmokers. 5-HTT-genotype showed no significant effect on smoking behavior. DISCUSSION: The results indicate a higher serotonergic activity in smokers as compared to nonsmokers independent of 5-HTT-genotype. Since former smokers and never smokers showed similar LDs, the serotonin enhancing effect of smoking seems to be a characteristic state, which may contribute to the maintenance of smoking behavior.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025417     DOI: 10.1055/s-2005-871237

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  5 in total

1.  Tobacco use is associated with reduced amplitude and intensity dependence of the cortical auditory evoked N1-P2 component.

Authors:  Philippe Jawinski; Nicole Mauche; Christine Ulke; Jue Huang; Janek Spada; Cornelia Enzenbach; Christian Sander; Ulrich Hegerl; Tilman Hensch
Journal:  Psychopharmacology (Berl)       Date:  2016-03-17       Impact factor: 4.530

2.  Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking.

Authors:  Undine E Lang; Thomas Sander; Falk W Lohoff; Rainer Hellweg; Malek Bajbouj; Georg Winterer; Jürgen Gallinat
Journal:  Psychopharmacology (Berl)       Date:  2006-12-21       Impact factor: 4.530

3.  Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression: a pilot study.

Authors:  Idun Uhl; Franciska Illes; Vanessa Graßnickel; Silke Echterhoff; Christine Norra; Georg Juckel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-02-18       Impact factor: 5.270

4.  Persistent dysfunctional frontal lobe activation in former smokers.

Authors:  Andres Neuhaus; Malek Bajbouj; Thorsten Kienast; Peter Kalus; Dorothea von Haebler; Georg Winterer; Jürgen Gallinat
Journal:  Psychopharmacology (Berl)       Date:  2006-04-13       Impact factor: 4.530

5.  Relationship Between the Loudness Dependence of the Auditory Evoked Potential and the Severity of Suicidal Ideation in Patients with Major Depressive Disorder.

Authors:  Mingyu Hwang; Yeon Jung Lee; Minji Lee; Byungjoo Kang; Yun Sung Lee; Jaeuk Hwang; Sung-Il Woo; Sang-Woo Hahn
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.